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2602Objectives: A uniform management strategy has not been established for the treatment of large ventricular
fibromas identified in children. The goal of the present study was to review our experience with surgical
resection of this uncommon tumor.
Methods:We performed a retrospective review of all patients with a diagnosis of ventricular fibromas who had
undergone surgical intervention at our institution from July 1990 to June 2013. The clinical records and
pathology reports were reviewed and available follow-up data obtained.
Results: A total of 20 patients had a ventricular fibroma. The median age at presentation was 4 years (range,
5 months to 12 years). Of these, 18 (89%) presented with ventricular tachycardia (n ¼ 15) or frequent ectopy
(n ¼ 3), and 1 (6%) with outflow tract obstruction; 1 (6%) was asymptomatic and diagnosed during routine
evaluation for a murmur. One patient had undergone previous ablation, and one had had an automated internal
cardiac defibrillator implanted for ventricular tachycardia control. Before tumor resection at our institution,
1 patient had been listed for transplantation at an outside institution and 1 had undergone previous extracardiac
Fontan without tumor resection. All patients underwent successful tumor excision with no recurrence of
ventricular arrhythmia during a median follow-up period of 3.3 years (range, 1 month to 14.7 years). One patient
underwent planned staged tumor resection. No patient died.
Conclusions: Primary ventricular fibromas, even when very large, can be managed by surgical resection, with
excellent short- and intermediate-term ventricular function and relief of arrhythmic events. (J Thorac Cardiovasc
Surg 2014;148:2602-8)Benign cardiac tumors represent 75% of all cardiac tumors,
which have an incidence of 0.001% to 0.3% in autopsy
series. Cardiac fibromas represent the second most common
benign pediatric tumor.1-3 Autopsy studies of fibroma were
reported as early as 1855, and the first case reports were
published in 1949.4 Since then, these tumors have been
described in numerous case reports.5,6 Although major
strides have been made in establishing the diagnosis,
especially with noninvasive imaging,7 management
strategies, in particular, surgical strategies, have not been
well-defined.8-23
The goal of the present study was to review our
institutional experience with surgical management of
ventricular fibromas, with special attention to the surgical
techniques used for successful resection and amelioration
of the potentially life-threatening arrhythmias. We chose
to focus on the outcomes of patients who had undergone
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The Journal of Thoracic and Cardiovascular Surbecause reports have varied on the ideal management of
these tumors and have included resection, transplantation,
and single ventricle palliation.METHODS
A retrospective review of all patients with a tissue diagnosis of
ventricular fibroma who had undergone tumor resection at our institution
from July 1990 to June 2013 was performed. The institutional review board
approved the conduct of our review. We queried our cardiac surgical,
cardiology, echocardiography, and pathology databases during the study
period for all patients who presented to our institution with a diagnosis
of fibroma. The clinical records were reviewed for clinical history and
operative data. The reports of all pre- and postoperative imaging
studies, including echocardiograms; magnetic resonance imaging, cardiac
catheterization, and electrophysiologic studies; electrocardiograms; and
Holter monitor studies were reviewed. The pathology reports were
examined for confirmation of the diagnosis. All operative reports were
reviewed to document the surgical technique at resection. Special attention
was given to the tumor location and completeness of resection.RESULTS
From 1990 to 2013, 153 patients were identified with
cardiac tumors: 92 rhabdomyoma, 26 fibroma, 10 myxoma,
5 vascular, 3 teratoma, 3 lipoma, and 14 other tumors. In this
group of 153 patients, 53 underwent cardiac tumor
resection, with resection of ventricular fibromas in
20 patients. All patients who were referred to our center
for symptoms underwent resection; none were deemed
inoperable or considered for palliative procedures, such as
single ventricle palliation, and none were evaluated forgery c December 2014
Abbreviation and Acronym
ECMO ¼ extracorporeal membrane oxygen
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Dtransplantation. Of these 20 tumors, 18 were located in the
left ventricle and 2 in the right. The distribution between
males and females was equal (10 each). The median age
at resection was 4.2 years (range, 5 months to 12 years).
The median follow-up duration was 3.3 years (range,
0.1-14.7 years). No patient died. One patient who had had
2 separate large tumors required staged resection, with
removal of the anteroseptal tumor first, followed by removal
of the second tumor arising in close proximity to the
atrioventricular groove, in a subsequent procedure. Seven
patients required additional intracardiac work (atrioventri-
cular valve repair in 5, patent foramen ovale closure in 1,
and Fontan conversion in 1). Of the 20 patients, 18 (90%)
presented with some form of ventricular arrhythmia,
ranging from frequent premature ventricular beats to
sustained or nonsustained ventricular tachycardia; with 1
patient experiencing a ventricular fibrillatory arrest. One
patient was referred after undergoing staged single ventricle
management, including Stansel connection at birth and,
later, an extracardiac Fontan. One patient had been deemed
inoperable and listed for transplantation at an outsideTABLE 1. Summary of patient and procedure characteristics (n¼ 20)
Characteristic Value
Preoperative
Male gender 10 (50%)
Median age (y) 4.21 (0.44-12.45)
Weight (kg) 16.9 (6.9-55.9)
Preoperative findings
Asymptomatic 1
Ventricular arrhythmias 18
RVOTO 1
Intraoperative
Median on-pump time (min, n ¼ 20) 112 (62-363)
Median fibrillatory time (n ¼ 8) 52 (5-233)
Median crossclamp time (n ¼ 10) 70 (8-98)
Associated procedure (6/20 patients [30%])
Biventricular conversion from Fontan 1
Mitral valve repair 4
Tricuspid valve repair 1
PFO closure 3
Postoperative
ECMO 2
Median length of stay (d) 7 (4-33)
Median follow-up (y) (n ¼ 17/20*) 3.3 (1 mo to 14.7 y)
Death 0
Reoperation 0
Ventricular arrhythmia 0
Data presented as median (range) or n (%). RVOTO, Right ventricular outflow tract
obstruction; PFO, patent foramen ovale; ECMO, extracorporeal membrane oxygen.
*The 3 patients lost to follow-up were all from outside the United States.
The Journal of Thoracic and Carinstitution, before successful tumor resection at our institu-
tion. There was no recurrence of arrhythmia postoperatively
in any of the 20 patients during early and late follow-up. The
patient and tumor characteristics are listed in Table 1, the
imaging characteristics in Table 2, and the individual
patient data in Table 3. A graphic representation of the
tumor location is presented in Figure 1. Figure 2 shows
the magnetic resonance imaging, intraoperative, and
histologic findings from a representative case.Surgical Technique
All procedures were performed with cardiopulmonary
bypass and moderate hypothermia (28C in 11, 25C in
5). More recently, 7 patients underwent this procedure using
a lower hemisternotomy with excellent tumor visualization.
All but 2 patients had undergone bicaval cannulation. Early
in our experience, cardioplegic arrest was used in 3 patients.
In the more recent era (since 2004), resection has been
performed with a beating heart in 5. In the other 12 patients,
tumor resection was performed with the patient under
fibrillatory arrest (induced in 6 and spontaneous in 6),
because this was believed to allow better delineation of
the epicardial coronary arteries that needed to be preserved.
Six patients had undergone tumor resection with a beating
or fibrillating heart and then underwent cardioplegic arrestTABLE 2. Preoperative and postoperative findings
Variable
Preoperative
findings (n ¼ 20)
Postoperative
findings (n ¼ 14)
LVEF echocardiogram (n)
>55% 19 11
40%-55% 1 3
<40% 0 0
LVEF MRI
Mean  SD 61  10 NA
Median 64
Range 35-72
LVEDVi MRI
Mean  SD 78  18 NA
Median 81
Range 38-115
Tumor length (cm)
Mean  SD 5.4  1.3 NA
Median 5
Range 3-8.6
Associated findings (n)
Residual AVVR* NA 4
Residual tumory 8
RVOT aneurysm 1
Arrhythmia 18 0
LVEF, Left ventricular ejection fraction; MRI, magnetic resonance imaging;
SD, standard deviation; NA, not applicable; LVEDVi, left ventricular end-diastolic
volume indexed; AVVR, atrioventricular valve regurgitation; RVOT, right ventricular
outflow tract. *Unchanged or improved from preoperatively. yThin rim adjacent to
vital structures.
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TABLE 3. Detailed patient characteristics of ventricular fibromas (presenting symptoms, tumor location, follow-up data)
Pt. no. Age Presentation Preoperative workup Tumor location Preoperative arrhythmia
1 7.5 mo Murmur
RVOTO
Echo
MRI
RV free wall to left of RVOT, with
RVOTO
None
2 7 mo URI symptoms, FTT Echo, MRI Anterolateral LV free wall from base
to ALPM and extending
over proximal LCA
Holter 132 VPB
3 6 y Palpitation Echo, MRI PL LV free wall from base to apex Holter 438 PVCs, 74 runs of VT
4 6 y Ectopy during T&A Echo, MRI Inferoseptal and apical wall of LV Vent ectopy
5 3 y Murmur Echo, EPS, Cath, MRI Intramyocardial LV mass involving
high septum and anterolateral wall
Holter-nonsustained VT, PVCs,
couplets, bigeminy
6 10.5 y CXR for URI symptoms Echo, Cath LV apical anterolateral free wall and
anterior septum
ETT isolated, multifocal and slow
ventricular couplets, ventricular
triplets, and one 4-beat run of
slow VT
7 12.5 y Tachycardia during a febrile illness Echo, MRI
EPS, Cath
Anterolateral free wall Sustained monomorphic VT
8 4.5 y CXR for URI Echo, Cath LV free wall from level of ALPM to
just above LV apex
Holter- occasional PVC, 2 couplets,
1 triplet, one 6 beat run of
accelerated idioventricular rhythm
9 11 y ER admission with SOB Echo Apical LV mass, extension into ALPM Recurrent VT
10 6 y Wide complex tachycardia
hemiparesis, factor V Leiden
mutation
Echo, MRI Lateral aspect of LV free wall, possible
involvement of ALPM
Sustained VT
11 4 y Vfib arrest at 2 mo Echo, MRI Tumor involving inferior and
inferolateral wall of LV, closely
associated with PMPM
Vfib arrest at 2 mo, subsequent runs of
monomorphic VT on Holter despite
antiarrhythmic agents
12 4 y Wide complex tachycardia Echo, EPS, Cath Tumor along inferolateral wall of LV Wide complex tachycardia, EPS 1,
spontaneous self-resolving VT,
inducible VT 3 2 foci requiring
cardioversion
13 8 mo Murmur Echo, Cath, MRI IVS from base to apex, abutting
PMPM and commissure
No preoperative arrhythmia, referred
to surgery for increasing tumor size
14 5 mo Diagnosis on fetal Echo Echo, Cath,
EPS, Cath
Lateral wall of LV extending from base
to apex
Monomorphic VT, inducible VT on
EPS
15 4.5 y Presyncope Echo, MRI Anterolateral and lateral wall from
base to midway to apex
Presyncope nonsustained VT
16 2 y Murmur Echo, MRI, Cath LV free wall extending from
base to 2/3 of distance to apex, mild sub-AS
Non sustained VT on Holter, inducible
poly- or monomorphic VT on EPS
17 10 mo VT Echo, MRI, CT Inferior LV wall extending from base
to apex, no OTO
VT
18 5.3 y Ventricular arrhythmias Echo, MRI Anteroseptal wall extending to base
of LV
Premature ventricular beats, unifocal
19 7.5 mo VT Echo, MRI, Cath Anteroseptal, anterior and
anterolateral segments, extending
from base to nearly apex
VT
20 8.5 y VT Echo, MRI Anterior free wall right ventricle Asymptomatic VT on Holter
Pt. no., Patient number; RVOTO, right ventricular outflow tract obstruction; FU, follow-up;; Echo, echocardiogram; MRI, magnetic resonance imaging; RV, right ventricular/
ventricle; RVOT, RVoutflow tract;URI, upper respiratory infection; FTT, failure to thrive; LV, left ventricular/ventricle; ALPM, anterolateral papillary muscle; LCA, left coronary
artery; VPB, ventricular premature beat; PL, posterolateral; PVCs, premature ventricular contractions; VT, ventricular tachycardia; T&A, tonsillectomy and adenoidectomy;
EPS, electrophysiologic study; Cath, cardiac catheterization; CXR, chest radiograph; ETT, exercise test; LAD, left anterior descending (artery); LCA, left coronary artery;
EF, ejection fraction; ER, emergency room; AICD, automatic implantable cardioverter defibrillator; AV, atrioventricular; PFO, patent foramen ovale; Vfib, ventricular fibrillation;
IVS, interventricular septum; PMPM, posteromedial papillary muscle; MV, mitral valve; AS, aortic stenosis; MR, mitral regurgitation; OTO, outflow tract obstruction.
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Dfor inspection of the atrioventricular valve or subaortic
region or for patent foramen ovale closure. The left heart
was decompressed by a right superior pulmonary vein
vent. Once cardiopulmonary bypass had been initiated,2604 The Journal of Thoracic and Cardiovascular Surcareful examination of the tumor for its proximity to the
major coronary arteries and atrioventricular grove was
performed, and the ideal incision site for resection was
determined. The epicardial incision was made, taking caregery c December 2014
Surgery FU duration
Reintervention
after discharge Current status
Complete resection of RV mass 14.7 y None 2.8 3 1.5 cm RVOT aneurysm, no arrhythmia
Near complete resection of LV fibroma 11.5 y None Mild global LV systolic dysfunction, no arrhythmias
Complete resection of LV tumor 1 mo None Lost to FU
Complete resection of LV apical tumor 1 mo None Lost to FU
Subtotal Excision of LV fibroma, (thin rim of tumor to
protect epicardial coronaries and septum)
8.6 y None Normal LV function on echo, residual tumor on MRI in
anterior basal septum, no arrhythmias
Resection of LV tumor, a thin rim of residual tissue beneath
LAD, PFO closure
8.4 y None Apex and apical portion of LV thin and slightly echo-bright, ,
mildly generous aortic annulus, no arrhythmia
Excision of LV tumor, with a thin rim of tumor beneath LCA
and ventricular septum
8.9 y None Mildly dilated LV with minimally depressed function EF
49.7%, Holter: VPBs with no runs of VT
Complete excision of LV tumor 9 y None Good LV function, Holter single isolated PVC
Complete excision of tumor, and removal of AICD leads 6.9 y None Low normal LV function, EF 42.8%, no arrhythmia
Excision of tumor leaving a thin rim of tumor at AV groove
and under diagonal branch, PFO closure
5.5 y None Residual hemiparesis, no significant change in residual
tumor size, no arrhythmia
Complete tumor resection 4 y None Well, no arrhythmia
Total tumor excision 1 mo None Lost to FU
Enucleation of apical tumor, MV plasty, and sub-AS
inspection
3.7 y Planned staged resection
LV, septal fibroma mitral
valvuloplasty, sub-AS
resection
Mild LV dysfunction, EF 42%, moderate MR unchanged
from previously, no LVOTO, no residual tumor, no
arrhythmia
Resection of tumor, leaving behind a thin rim of tumor at AV,
MV plasty
2.5 y None Mild global LV dysfunction, improved from previous, large
cavernous region near LV apex, mild MR, no LVOTO
Holter: 3 PVC, 3 PAC
Complete tumor excision 3 y None Well, no arrhythmia, no recurrence
Major tumor debulking, ligation of coronary branch running
into tumor
1.5 y None Well, no arrhythmia
Total excision of LV fibroma, MV repair 6 mo None Well, no arrhythmia
Excision of LV fibroma biventricular conversion from
Fontan, ECMO
5 mo None Well, no arrhythmia
Excision of LV fibroma, mitral valvuloplasty, ECMO 4 mo None Well, no arrhythmia
Excision of RV fibroma, tricuspid valvuloplasty, PFO
closure
2 mo None Well, no arrhythmia
TABLE 3. Continued
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Dto avoid the coronary arteries, at the point of maximal
prominence of the tumor, and the incision was continued
parallel to the major coronary arteries. The plane between
the epicardium and tumor was developed and was oftenThe Journal of Thoracic and Carwell-delineated, because the tumor had a typical whitish
fibrous texture. Every attempt was made to enucleate the
entire tumor. Occasionally, transmural resection with entry
into either ventricular cavity was required. A thin layer ofdiovascular Surgery c Volume 148, Number 6 2605
FIGURE 1. Location of fibromas. Most were in the left ventricular (LV)
free wall. RV, Right ventricular.
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Dresidual tumor was left behind if it had extended close to the
atrioventricular groove or close to a major epicardialFIGURE 2. Resection of a large left ventricular fibroma in a 7-month-old girl w
of the tumor along the plane of the normal myocardium. B, T1-weighted magne
anatomic features of the mass. C, Gross pathologic specimen showing a som
showing dense collagen, focal necrosis, and calcifications (arrow). LV, Left ven
2606 The Journal of Thoracic and Cardiovascular Surcoronary artery. Once complete or near complete tumor
resection had been confirmed by the presence of viable
myocardial tissue in the tumor bed, the tumor bed was
obliterated with interrupted pledgetted Prolene sutures in
layers, taking care to avoid any kinking of the epicardial
coronary arteries. In most cases, the epicardium was
reapproximated over the obliterated tumor bed with fine
Prolene sutures. If any concern for coronary compromise
was present, the tumor bed was left partially open. Any
intracardiac work that was required (eg, inspection and/or
repair of the atrioventricular valve, inspection of the left
ventricular outflow tract, closure of a patent foramen ovale)
was then performed with the patient under cardioplegic or
fibrillatory arrest. The left heart was de-aired, and the pa-
tients were weaned off cardiopulmonary bypass once they
had been rewarmed. Atrial and ventricular wires were
routinely placed, and all but 4 patients underwent primary
chest closure.
Concomitant atrioventricular valve repair was performed
in 5 patients (4 mitral valve and 1 tricuspid valve). Thisith ventricular tachycardia. A, Intraoperative photograph showing resection
tic resonance image of the tumor in the ventricular short-axis showing the
ewhat inhomogeneous white-gray solid tumor mass. D, Photomicrograph
tricle; RV, right ventricle; T, tumor.
gery c December 2014
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Dincluded release of tethering cords of the anterior mitral
leaflet at the posteromedial commissure, reapproximation
of the anterior mitral leaflet, and annuloplasty; partial
closure of the anterolateral commissure, which was splayed
open; anterolateral and posteromedial commissuroplasty
for prolapse of the posterior mitral leaflet; release of the
abnormal attachments at anterolateral commissure with
partial closure of the commissure; and anteroseptal
commissure closure and commissuroplasty to reduce
tricuspid valve annulus. During follow-up, all patients had
stable or an improved grade of atrioventricular valve
regurgitation.
Only 3 patients experienced ventricular tachycardia with
weaning off of cardiopulmonary bypass. One responded to
intravenous lidocaine and a lidocaine infusion was
continued for 72 hours postoperatively. The second required
reinstitution of cardiopulmonary bypass and take down of
the left internal mammary artery in preparation for coronary
artery bypass grafting owing to concerns of ischemia in the
circumflex coronary territory. However, this patient
subsequently recovered normal function and was free of
ectopy after a period of support with cardiopulmonary
bypass and did not under go coronary artery bypass graft.
In both these patients, the chest was left open, with
tourniquets in place; however, they did not require any
additional intervention, and the chest was closed within
the next 24 hours in the first patient and 72 hours in the
second patient. The third patient was weaned off
bypass onto extracorporeal membrane oxygen (ECMO)
support for ventricular arrhythmias that had responded to
lidocaine. This patient required ECMO for 3 days and
was successfully decannulated.
In addition, the patient who had undergone tumor
resection followed by biventricular conversion from Fontan
circulation was electively supported with ECMO for left
atrial hypertension, with a plan for continued postoperative
mechanical support to allow for left ventricular remodeling.
This patient continued with ECMO support for 5 days and
required peritoneal dialysis for acute renal failure. The
patient was successfully decannulated on postoperative
day 5, with subsequent resolution of the renal dysfunction.
Most patients were extubated within 24 to 72 hours of
surgery (except for the 2 patients requiring mechanical
support; 1 remained ventilated for 14 days and 1 for 8
days). Only 1 patient had a period of junctional rhythm
postoperatively; however, no ventricular arrhythmia was
documented in the postoperative period in any patient.
The findings of a postoperative ventricular stimulation
study in 7 patients using their epicardial wires were all
negative. Of the 20 patients, 14 (70%) had been placed
on antiarrhythmic agents preoperatively and 11 (55%)
were discharged with antiarrhythmic medication. During
the follow-up period, 4 (24%) of the 17 patients with
long-term follow-up data available continued withThe Journal of Thoracic and Carantiarrhythmic medication as prophylactic therapy. None
of the 17 patients had evidence of ventricular tachycardia
or fibrillation on Holter monitoring during the follow-up
period.
DISCUSSION
Ventricular fibromas are rare primary cardiac tumors. In
our series, we treated 20 patients from 1990 to 2013, with
19 of the 20 treated after 2001. The management strategy,
in particular, the surgical approach has not been well
established. The large tumor size in relationship to the ven-
tricular chamber has often been considered a limiting factor
for complete excision. In our experience, all but 1 of the tu-
mors could be resected in their entirety, independent of the
tumor size, tumor location, or patient age.
Several isolated case reports and small case series
of complete or partial excision8-15 have been published, and
these have included techniques such as the Batista
ventriculoplasty and Dacron patch sandwich for closure of
the tumor bed after resection. The alternative management
approaches to cardiac fibroma reported by others included
functional single ventricle palliation,16 single ventricle palli-
ation as a bridge to transplantation,17 partial excision with
single ventricle palliation,18 initial single ventricular pallia-
tion followed by resection,19 staged resection,20 and ortho-
topic heart transplantation as a primary surgical option for
large fibromas, in particular, those involving the interventric-
ular septum.21,22
The largest series to date on the management of cardiac
fibroma was reported by Burke and colleagues,23 who
reported on 23 patients, including adults and children.
Of these, 21 had ventricular fibromas; 13 (8 children and
5 adults) underwent resection (8 simple excisions, 4
incomplete excisions, and 5 complex resections, including
patching of myocardial defects, valve replacement, or
coronary artery bypass grafting). They reported 2 deaths
in this group of 13. The group from the Mayo Clinic24
reported their experience with surgical resection of
ventricular fibromas from 1964 to 2002. That cohort
included 12 children (median age, 3 years; range,
0.2-12.4) and 6 adults. Three patients had been referred to
their center for cardiac transplantation. They had 1
intraoperative death. Similar to our experience, they
reported no recurrent arrhythmias or tumor recurrence in
the patients who survived surgery (median follow-up,
8.6 years; range, 0.4-33.4), but 2 did require subsequent
mitral valve replacement.
Recent review at our institution25 of a retrospective series
of cardiac tumors and associated arrhythmias during a
42-year period, found that surgical excision was effective
in the management of arrhythmias. This study included
13 of the patients in the current report.
The present series of 20 patients with cardiac fibromas in
multiple locations has demonstrated that surgical excisiondiovascular Surgery c Volume 148, Number 6 2607
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Dand, in most cases, complete enucleation, can be safely
performed, with acceptable postoperative ventricular
function and relief from potentially life threatening
arrhythmia. The mid-term follow-up data have shown no
recurrence of major arrhythmia or tumor. Late follow-up
data from this group are necessary to determine the long-
term efficacy of this approach, although the present length
of follow-up would indicate that ventricular dysfunction
would not appear to be a problem, despite the magnitude
of the tumor at excision. Although single ventricle pallia-
tion or orthotopic transplantation could be considered as
an alternative, all our patients were successfully treated
with, predominantly, complete excision. In the 8 patients
who underwent near total excision with a small rim of
residual tumor, none have required reoperation to date,
and none have developed recurrent ventricular arrhythmia.
Study Limitations
The present study was a retrospective review; therefore,
the follow-up data were not complete for all patients, with
a median follow-up period of only 3.4 years. Three patients
were lost to follow-up, because they had been referred to us
from outside the United States. Despite extensive effort, we
were unable to obtain any follow-up information. In
addition, 4 patients from our cohort of 20 had undergone
surgery within the previous 12 months (3 in the previous
6 months). If we excluded those lost to follow-up and those
treated within the past 1 year, the median follow-up period
would be 6.9 years (range, 2.5-11.5) for those treated since
2001.
Our review only included patients who had undergone
surgical resection for symptomatic ventricular fibroma at
our institution. Our study was not a comprehensive review
of all ventricular tumors. In the same period, 6 additional
patients had a diagnosis of fibroma determined by the
magnetic resonance imaging characteristics. All these
patients were asymptomatic, with no history of arrhythmia,
and are followed conservatively.CONCLUSIONS
Large ventricular fibromas can be safely managed
with primary total or near total excision, with relief of
life-threatening arrhythmias and excellent clinical results.
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